相关产品推荐更多 >

ruvA抗体ruvA兔多抗抗体EC 3.6.4.12 antibody抗体ruvA Antibody, HRP conjugated抗体
¥880
RBM6抗体RBM6兔多抗抗体RNA-binding protein DEF-3 antibody抗体RBM6 Antibody, HRP conjugated抗体
¥880
MBD3抗体MBD3兔多抗抗体Methyl-CpG-binding protein MBD3 antibody抗体MBD3 Antibody, FITC conjugated抗体
¥880
NOB1抗体NOB1兔多抗抗体RNA-binding protein NOB1 antibody抗体NOB1 Antibody抗体
¥440
PIP抗体PIP兔多抗抗体Secretory actin-binding protein antibody抗体PIP Antibody抗体
¥440
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
细胞污染识别与处理全攻略:5 种常见类型+关键误区abinScience 体内级抗体,年度锁价,低至 1200五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Human Mothers against decapentaplegic homolog 1 protein (202-335AA)
- 亚型:
IgG
- 形态:
Liquid
- 保存条件:
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性:
Polyclonal
- 标记物:
HRP
- 适应物种:
Human
- 保质期:
6个月
- 抗原来源:
Homo sapiens (Human)
- 目录编号:
Q15797
- 级别:
优
- 库存:
200
- 供应商:
武汉华美生物工程有限公司
- 宿主:
Rabbit
- 应用范围:
ELISA
- 浓度:
>95%,Protein G purified
- 靶点:
SMAD1
- 抗体英文名:
SMAD1 Antibody, HRP conjugated
- 抗体名:
Transforming growth factor-beta-signaling protein 1 antibody
- 规格:
100μg/50μg
| 规格: | 100μg | 产品价格: | ¥1320.0 |
|---|---|---|---|
| 规格: | 50μg | 产品价格: | ¥880.0 |
保存缓冲液
Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
功能
Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD1 is a receptor-regulated SMAD (R-SMAD). SMAD1/OAZ1/PSMB4 complex mediates the degradation of the CREBBP/EP300 repressor SNIP1. May act synergistically with SMAD4 and YY1 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression.风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Regulator of Epidermal Growth Factor Signaling: Sprouty
Sprouty was first discovered through its downregulatory effect on fibroblast growth factor (FGF) receptor pathway during tracheal development. Sprouty expression is also induced by the epidermal growth factor receptor (EGFR) cascade
Insulin and Growth Factor Signaling: Effects on Drug-Metabolizing Enzymes
and growth factors. The first major section of the chapter defines the major insulin- and growth factor-mediated signaling pathways implicated in regulating drug-metabolizing enzyme expression, including those involving mitogen-activated protein
MicroRNA Regulation of Growth Factor Receptor Signaling in Human Cancer Cells
Aberrant expression of the epidermal growth factor receptor (EGFR) and/or human epidermal growth factor receptor 2 (HER2) is a feature of many human tumors and is associated with disease progression, treatment resistance, and poor prognosis
技术资料暂无技术资料 索取技术资料






